The 2023 META:PHI Virtual Conference was held Sept 22-23, 2023. Thanks so much to everyone who participated as presenter and/or attendee. There will be no 2024 Conference, as the META:PHI Annual Conference is being moved to spring 2025. Thank you for your patience and we hope to see you then!
Please see below for recordings and presentation slides from previous conferences.
Thank you to the conference planning committee for their input and expertise in the planning of this event:
Jennifer Wyman (Chair)
Rachel Alexander
Sara Bown
Leslie Buckley
Janelle Hannon
Christina Henry
Leslie Molnar
Lori Regenstreif
Michael Roach
Maria Zhang
Thank you also to Lisa Bromley, Ann Marie Corrado, Robin Griller, and Anita Srivastava for acting as moderators, and to all speakers and attendees for their participation.
| Welcome Jennifer Wyman, Conference Chair Meldon Kahan, Medical Director, META:PHI Ann Marie Corrado, Acting Network Director, META:PHI Keynote Re-positioning Methadone Maintenance Treatment (MMT) within the context of criminalization David Frank, Research Scientist, New York University |
|
| Session 1B Family caregivers: Problem or panacea? Oona St-Amant, Associate Professor, School of Nursing, TMU Brynlea Barbeau, Addiction Medicine Physician, Sault Area Hospital Louise White, Co-Founder, FAR |
|
| Session 1C Toronto’s drug checking service: Clinical and community impacts of findings from the city’s unregulated drug supply Hayley Thompson, Project Manager, Toronto’s Drug Checking Service, CDPE Pat Fifield, OPSW, Parkdale Queen West CHC |
|
| Session 2A Pharmacological management of benzodiazepine dependence Josée Lynch, Addiction Psychiatrist, University Health Network |
|
| Session 2b Mashed versus meshed: Integrating psychosocial care into your RAAM Jared Bonis, Staff NP, Health Sciences North Alyssa Scichilone, RSW, Outpatient Addictions, Sudbury Mental Health and Addictions Centre Michael Roach, Regional Lead, Addictions Services, Mental Health and Addictions Programs, Health Sciences North |
|
| Session 2C Implementing contingency management in RAAM: A quality improvement project Tanya Hauck, Addiction Psychiatrist, CAMH Himmat Dhillon, M2, Midwestern University Medicine Basant Dhillon, Health Sciences, McMaster University Stephanie Rochon, RAAM Supervisor, Brant Community Health Care Systems |
|
| Session 3A Methadone, opioid overdose, and supervised consumption site data Tali Cahill, Professional Practice Consultant, Royal Ottawa Mental Health Centre |
|
| Session 3B Buprenorphine macrodosing in the ER and early depot buprenorphine initiation in the hospital setting Louisa Marion-Bellemare, Assistant Professor, Northern Ontario School of Medicine Julie Samson, Assistant Professor, Northern Ontario School of Medicine |
|
| Session 3C Developing and implementing a mobile addictions medicine service for Indigenous people in the GTA Harvey Manning, Director, Programs and Services, Anishnawbe Health Toronto Chetan Mehta, RAAM Physician, Anishnawbe Health Toronto Subo Awan, Interim Manager, Anishnawbe Health Toronto |
|
| Session 4A Alcohol withdrawal: A primer for RAAM clinicians Katie Dunham, Nurse Educator, META:PHI Meldon Kahan, Medical Director, META:PHI |
|
| Session 4B Transitions of care in addiction treatment Narges Beyraghi, Addiction Psychiatrist, CAMH Tianna Costa, Clinical Pharmacist, CAMH Amy Yang, Occupational Therapist, CAMH |
|
| Session 4C A new framework for methadone carries: A person-centered evidence-based approach to take-home dosing Vincent Lam, Medical Director, Coderix Medical Clinic Suzanne Latreille, Peer Educator, City of Ottawa Andrew McLeod, Community Consultant Charlotte Munro, Child and Youth Worker Jennifer Wyman, Medical Director, SUS, Women’s College Hospital Maria Zhang, Pharmacist, CAMH |
Workshop 1A
Withdrawal workshop: Manual review and case presentations
Katie Dunham, Nurse Educator, META:PHI
Laura Jones, NP, St. Leonard’s Withdrawal Management
Mark Weiss, Medical Director, Bellwood Health Services
Workshop 1B
Onboarding peers as team members in addictions care settings
Ethan Hopkins, Peer Systems Navigator, Support House
Alyssa Gremmen, Peer Integration and Systems Lead, Support House
Richard Adair, Manager, Peer Services, Peer Support House
Workshop 1C
A taste of Motivational Interviewing
Wiplove Lamba, Physician Lead, SUS, Sinai Health Systems
Omar Ghaffar, Physician Lead, Mental Health, Hennick Bridgepoint Hospital
Hedieh Ghanbari, Hospital Medicine Director, Sinai Health Systems
Mary Zheng CNS, Hennick Bridgepoint Hospital
Anita Kang, PGY 5 (psychiatry), University of Toronto
Workshop 2A
Mandatory reporting to the Ministry of Transportation: Considerations and review of the legislation
Tanya Hauck, Addictions Psychiatrist, CAMH
Omar Ha-Redeye, Lawyer, Fleet Street Law
Workshop 2B
Treatment of hepatitis C in addiction settings
Jordan Feld, Interim Director, Toronto Centre for Liver Disease, University Health Network
Hemant Shah, Staff Hepatologist, University Health Network
Workshop 2C
Collaborative approaches to care with adolescents who use substances
Jessica Empringham, PGY-3 (Paediatrics), SickKids
Karen Leslie, Staff Paediatrician, SickKids
Cathy Maser, NP, SickKids
Thank you to our conference planning committee for their input and expertise in the planning of this event:
Jennifer Wyman (Chair) MD CCFP FCFP DABAM MPH
Rachel Alexander BAH
Leslie Buckley MD MPH FRCPC
Christina Henry RN BScN BA
Sean LeBlanc, CAPUD
Leslie Molnar MSW RSW
Lori Regenstreif MSc MD CCFP(AM) MScCH(AMH) FCFP
Josh Richardson RP RPN Psych Cert BAH
Anita Srivastava MD MSc CCFP
Maria Zhang BScPhm, PharmD
| Welcome Kate Hardy, Network Director, META:PHI Meldon Kahan, Medical Director, META:PHI Plenary Supporting First Nations right to health: What is the critical path? Dr. Carol Hopkins OC, Chief Executive Officer, Thunderbird Partnership Foundation |
|
| Desperate times call for desperate measures: Breaking the barrier for treatment of OUD using macrodosing & depot buprenorphine Louisa Marion-Bellemare MD CCFP Julie Samson MD CCFP (EM) Timmins District Hospital Opioid Withdrawal Protocol Timmins District Hospital Admission Order Set |
|
| Session 3A Opioid agonist treatment and the opioid crisis Meldon Kahan MD CCFP FRCPC |
|
| Session 4A Re-imagining philosophies of care: Hiring, training, and mentorship of nurses in CTS Erin Telegdi RN, South Riverdale CHC Lara Small RN, South Riverdale CHC Jessica Arteaga RN, South Riverdale CHC Sushi Rosborough, Overdose Response Worker, South Riverdale CHC |
|
| Session 4B STOPS – A journey of grassroots overdose prevention from Northeastern Ontario Karla Ghartey, STOPS Program Crystal Kimewon, STOPS Program Marie Pollock, STOPS Program |
|
| Session 5A Medically supported alcohol withdrawal management: Outpatient and detox perspectives David Peterson NP-PHC MSc BNSc BPHE BSc Shawn Dookie NP-PHC RN (EC) BSc MPH |
|
| Session 5B Addressing stigma through clinical judgment: Strategies for working with families Oona St-Amant RN PhD Angie Hamilton, Executive Director, Families for Addiction Recovery Brynlea Barbeau MD |
|
| Session 6A Downtown east community-led trauma informed overdose response curriculum Seff Pinch, South Riverdale CHC Sunny Sultan, South Riverdale CHC |
|
| Session 7A 5 years of treating perinatal substance use disorder at Kingston Health Sciences Centre Adam Newman MD FCFP (AM) CCSAM |
|
| Session 7B From grief to advocacy: Family journeys to demanding safe supply, decriminalization and harm reduction Christine Wingate, Ontario Director, Moms Stop the Harm Missy McLean, Ontario Director, Moms Stop the Harm |
|
| Session 8A Monthly depot buprenorphine XL: The first 100 patients (London RAAM Clinic) Ken Lee MD MCFP (AM) |
|
| Session 8B A rural approach to the opioid crisis Micayla Ahearn MD Victoria Burke, ROCK Outreach Worker Sean Lee-Popham RN, Harm Reduction Lead, Bancroft Community FHT Ellen Buck-McFadyen PhD, Trent University School of Nursing |
|
| Session 9A Drug decriminalization Matthew Bonn, Program Manager, CAPUD Sandra Ka Hon Chu, Co-Executive Director, HIV Legal Network |
|
| Session 9B The structure, growth, and development of an addiction rural service: An inter-professional multi-regional community-wide approach Connie Foster NP-PHC MSc Katie Hogue NP-PHC |
|
| Session 9C Inpatient naloxone kit distribution: Our first steps into hospital-based harm reduction initiatives Michael Roach, NE Ontario Regional Lead, RAAM and AMCT Paola Nikodem, Regional Education and Quality Lead for Addictions Services, Health Sciences North |
Workshop 1
Digging in to buprenorphine: Initiating and managing buprenorphine in ambulatory, ED, and inpatient settings
Katie Dunham BSc Hons BScN MN NP-PHC
Melissa Holowaty PhD MD CCFP (AM)
Robyn Nocilla BScN MSc NP-PHC
Mike Postic MSc NP-Adult
Elizabeth Shouldice MD MPH CCFP (EM) FCFP
Jennifer Wyman MD CCFP FCFP DABAM MPH
Workshop 4
Methadone treatment for people who use fentanyl: Using case discussions to explore the META:PHI guidelines
Lisa Bromley MD CCFP (AM) FCFP
Robin Lennox MD CCFP
Meredith MacKenzie MD BSc CCFP (AM) FCFP
Andrew McLeod
Lori Regenstreif MD CCFP (AM) FCFP MScCH (AMH) CISAM
Anita Srivastava MD MSc CCFP
Thank you to our conference planning committee for their input and expertise in the planning of this event:
Rachel Alexander BAH
Leslie Buckley MD MPH FRCPC
Katie Dunham BSc Hons, BScN, MN, NP-PHC
Kate Hardy MSW RSW
Christina Henry RN BScN BA
Louisa Marion-Bellemare MD CCFP (EM)
Josh Richardson RP RPN Psych Cert BAH
Michael Roach RN MN
Hasan Sheikh MD CCFP (EM) MPA
Jennifer Wyman MD CCFP FCFP DABAM MPH
Maria Zhang BScPhm, PharmD
| Session 1A Methadone treatment in the fentanyl era: New consensus guidelines Meldon Kahan MD CCFP FRCPC Lori Regenstreif MD CCFP (AM) FCFP MScCH (AMH) CISAM |
|
| Session 1B Resources and strategies to support vulnerable and marginalized patients in RAAM clinics Christina Henry RN BA BScN |
|
| Session 1C Caring for health professionals with SUD Adam Newman MD FCFP (AM) CCSAM Lisa Lefebvre MDCM MPH CCFP (AM) DABAM FASAM CCSAM CMRO Mark Weiss MD MCFP (AM) |
|
| Session 2A Co-prescribing for concurrent disorders Valerie Primeau MD FRCPC |
|
| Session 2B RAAM innovations (1) Lakeridge opioid navigator Lindsay Reynolds MEd RP (2) The Alex RAAM Jennifer Eyford MSc BSc BN RN |
|
| Session 2C Harm reduction for hospitalized patients and people who inject drugs Tali Cahill BScN RN |
|
| Panel Innovations in care for people with SUDs during COVID: What can we learn going forward? Moderator: Vincent Lam MD CCFP (AM) ASAM CSAM (1) Working with managed alcohol/managed stimulant programs during COVID Michelle Klaiman MD FRCPC DABAM (2) Virtual care Michael Roach, Regional Lead, Addictions Services, Mental Health and Addictions Programs, Health Sciences North (3) COVID-OAT changes Tara Gomes PhD MHSc |
|
| Session 3A Long-acting buprenorphine options Katie Dunham BSc BScN MN NP-PHC Ken Lee MD MCFP (AM) |
|
| Session 3B The roles of peer support and lived experience in addiction medicine Josh Richardson RP RPN Psych Cert BA Hons Charles Coke, Peer Support Advocate |
|
| Session 3C MI and brief interventions in the addictions setting Julie Henderson MD FRCPC DABAM Leslie Molnar MSW RSW |
|
| Session 4A Case discussions: Managing non-opioid substance use issues Jennifer Wyman MD CCFP FCFP DABAM MPH |
|
| Session 4B Family-centred care Angie Hamilton LLB BCL Louise Lemieux White BScN RN |
|
| Session 4C Contingency management Melissa Holowaty PhD MD CCFP (AM) |
Thank you to our conference planning committee for their input and expertise in the planning of this event:
Leslie Buckley MD MPH FRCPC
Katie Dunham BSc Hons, BScN, MN, NP-PHC
Kate Hardy MSW RSW
Christina Henry RN BScN BA
Elizabeth Shouldice MD CCFP(EM) FCFP MPH
Jennifer Wyman MD CCFP FCFP DABAM MPH
Maria Zhang BScPhrm, PhmD
Provincial overview and META:PHI supports – Kate Hardy (META:PHI), Sarah Clarke (META:PHI)
Clinical best practices in addiction medicine – Meldon Kahan MD CCFP FRCPC
Knowledge dissemination of addiction skills across clinical settings – Ken Lee MD MCFP(AM), Lori Regenstreif MD CCFP(AM) FCFP MScCH(AMH) CISAM, Jennifer Wyman MD CCFP FCFP DABAM MPH
Engaging community partners: Pilot with the Ontario Provincial Police – John Gorchinsky (OPP)
Engaging community partners: Collaborating with CAS – Ambreen Ladha (Children’s Aid Society of Toronto)
Engaging community partners: Building pathways with social services – Barbara Andrade (City of Toronto)
Management of substance-induced psychosis, depression, and anxiety – Darren Holub MD FRCPC FASAM DABAM CCSAM
Thunder Bay RAAM clinic: Trauma-informed progress – Julia MacArthur (Thunder Bay Counselling), Darcy McWhirter (St. Joseph’s Care Group), Georgina McKinnon (People Advocating for Change through Empowerment), Carleigh Taylor, Dilico Anishinabek Family Care
Making RAAMs accessible: Delivering culturally safe care to Indigenous clients – Sheryl Lindsay (Anishnawbe Health Toronto)
HIV and Hep C: Screening, educating, and referring patients in addiction settings – Courtney Thompson MD FRCPC MSc
Adjunct psychosocial services to RAAM – Leslie Molnar (Women’s College Hospital)
Challenges in OAT treatment in fentanyl users – Anita Srivastava MD MSc CCFP
Transfer of care to PCP letter template (alcohol / opioids)
Initial visit letter template
Discharge letter template
Microdosing
Children’s Aid Society of Toronto: How and why children enter CAS care
Child and Family Services: Reporting child abuse and neglect
FAR services
FAR summer newsletter
Introduction and welcome – Kate Hardy, Sarah Clarke (META:PHI)
Engaging patients in care: Lessons learned from the Ottawa RAAM clinic – Kim Corace, Melanie Willows (The Royal Ottawa Mental Health Centre)
Anishnawbe Health Toronto: Rapid Access to Addiction Medicine – Peter Wynne, Sheryl Lindsay, Leslie Saunders (Anishnawbe Health Toronto)
Considerations when working with women – Lindsay Williams (Breakaway Addiction Services)
Special population considerations: The older adult – Marilyn White-Campbell (Reconnect Community Mental Health Services)
Approaches for working with adolescents and youth who use alcohol and drugs – Sharon Cirone (St. Joseph’s Health Centre)
Substance use in pregnancy: Top 10 tips for working with pregnant women – Suzanne Turner (St. Michael’s Hospital)
Medical and psychosocial management of benzodiazepines, crystal meth, cocaine, and cannabis – Wiplove Lamba (St. Michael’s Hospital)
Engaging communities in the RAAM clinic process – Mike Franklyn, Stephanie Paquette, Paola Folino (Health Sciences North)
Supporting families of those who use substances – Irene Njoroge, Leslie Molnar (META:PHI)
Best practices for RAAM clinics – Meldon Kahan (META:PHI)
Developing community pathways – Camille Keith (META:PHI)
Emergency department care in the RAAM era: A critical partnership – Larry Nijmeh (Lakeridge Health)
Trauma-informed care – Leslie Molnar, Irene Njoroge (META:PHI)
76 Grenville St.
Toronto, ON M5S 1B2
416-323-6400 x7511
Kate Hardy
Network Director
Ontario Ministry of Health
Program Sponsor